These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 16987381

  • 1. Effect of cardiac resynchronization therapy in patients with moderate left ventricular systolic dysfunction and wide QRS complex: a prospective study.
    Fung JW, Zhang Q, Yip GW, Chan JY, Chan HC, Yu CM.
    J Cardiovasc Electrophysiol; 2006 Dec; 17(12):1288-92. PubMed ID: 16987381
    [Abstract] [Full Text] [Related]

  • 2. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB, Schalij MJ, Holman ER, Steendijk P, van der Wall EE, Bax JJ.
    Am J Cardiol; 2006 Jul 15; 98(2):230-5. PubMed ID: 16828599
    [Abstract] [Full Text] [Related]

  • 3. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Török T, Linde C, REVERSE Study Group.
    J Am Coll Cardiol; 2009 Nov 10; 54(20):1837-46. PubMed ID: 19800193
    [Abstract] [Full Text] [Related]

  • 4. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
    Ng K, Kedia N, Martin D, Tchou P, Natale A, Wilkoff B, Starling R, Grimm RA.
    Pacing Clin Electrophysiol; 2007 Feb 10; 30(2):193-8. PubMed ID: 17338715
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C, Ometto R, Pasinato S, Finocchi G, La Vecchia L, Fontanelli A.
    Ital Heart J; 2004 May 10; 5(5):364-70. PubMed ID: 15185900
    [Abstract] [Full Text] [Related]

  • 9. Sustained reverse left ventricular structural remodeling with cardiac resynchronization at one year is a function of etiology: quantitative Doppler echocardiographic evidence from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE).
    Sutton MG, Plappert T, Hilpisch KE, Abraham WT, Hayes DL, Chinchoy E.
    Circulation; 2006 Jan 17; 113(2):266-72. PubMed ID: 16401777
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
    Landolina M, Lunati M, Gasparini M, Santini M, Padeletti L, Achilli A, Bianchi S, Laurenzi F, Curnis A, Vincenti A, Valsecchi S, Denaro A, InSync/InSync ICD Italian Registry Investigators.
    Am J Cardiol; 2007 Sep 15; 100(6):1007-12. PubMed ID: 17826388
    [Abstract] [Full Text] [Related]

  • 13. Effect of long-term resynchronization therapy on left ventricular remodeling in pacemaker patients upgraded to biventricular devices.
    Vatankulu MA, Goktekin O, Kaya MG, Ayhan S, Kucukdurmaz Z, Sutton R, Henein M.
    Am J Cardiol; 2009 May 01; 103(9):1280-4. PubMed ID: 19406272
    [Abstract] [Full Text] [Related]

  • 14. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Haghjoo M, Bonakdar HR, Jorat MV, Fazelifar AF, Alizadeh A, Ojaghi-Haghjghi Z, Esmaielzadeh M, Sadr-Ameli MA.
    Europace; 2009 Mar 01; 11(3):356-63. PubMed ID: 19136489
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA, Bleeker GB, van der Wall EE, Schalij MJ, Bax JJ.
    Am J Cardiol; 2007 Dec 01; 100(11):1665-70. PubMed ID: 18036366
    [Abstract] [Full Text] [Related]

  • 18. Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction: the Homburg Biventricular Pacing Evaluation (HOBIPACE).
    Kindermann M, Hennen B, Jung J, Geisel J, Böhm M, Fröhlig G.
    J Am Coll Cardiol; 2006 May 16; 47(10):1927-37. PubMed ID: 16697307
    [Abstract] [Full Text] [Related]

  • 19. Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure.
    Bleeker GB, Schalij MJ, Molhoek SG, Verwey HF, Holman ER, Boersma E, Steendijk P, Van Der Wall EE, Bax JJ.
    J Cardiovasc Electrophysiol; 2004 May 16; 15(5):544-9. PubMed ID: 15149423
    [Abstract] [Full Text] [Related]

  • 20. Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy.
    Gradaus R, Stuckenborg V, Löher A, Köbe J, Reinke F, Gunia S, Vahlhaus C, Breithardt G, Bruch C.
    Heart; 2008 Aug 16; 94(8):1026-31. PubMed ID: 17984216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.